Table: begin end state 1 31 cytoplasmic 32 53 transmembrane 54 59 non-cytoplasmic 60 84 transmembrane 85 95 cytoplasmic 96 116 transmembrane 117 121 non-cytoplasmic 122 147 transmembrane 148 159 cytoplasmic 160 185 transmembrane 186 194 non-cytoplasmic 195 214 transmembrane 215 249 cytoplasmic 250 271 transmembrane 272 283 non-cytoplasmic 284 306 transmembrane 307 313 cytoplasmic 314 331 transmembrane 332 336 non-cytoplasmic 337 355 transmembrane 356 375 cytoplasmic 376 401 transmembrane 402 407 non-cytoplasmic 408 426 transmembrane 427 438 cytoplasmic
Input: >WP_052306240.1 NCBI__GCF_000020045.1:WP_052306240.1 MRDSTSGDSSANAAVDPKLLRRAAFASFIGNFVEWFDYASYGYLATIIAVVFFPKTDGSA GLLAAYGVFAISFIVRPVGGIVWGHFGDKIGRRASLSLSILIMSASTFVIALLPTYAQVG VLAPVLLLLVRVVQGFSASGEYAGASAFLAEYAPSNRRGFYTSIVPASTAAGLLFGSILI AIMHAVLSSEQLHSFGWRLPFLLAAPFGLIGRYIRVKLEDTPRFKALEQQSHVARAPIAE LLGKHRGKMLIAFGVTCLNAVAFYLVLSYMPTYLSTELGMDETASFIAATISLTAYIGLI FVMGALSDRLGRKSMLIGASILFAVLTVPLFKGLGGAGFMTIVAIQIAFGALLTMNDGTL PCFLSEIFPTRVRYSGFAFCFNAANALFGGTAPLVATWLIGATGSKLAPAWYLVGAAIVA LIAMSVSRETSHAPLADE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server